News

Biolex Therapeutics has entered into an agreement with Cook Pharmica under which Cook will manufacture drug substance for use in Biolex’s planned phase 3 clinical trials of Locteron.

Copan has announced the expansion of its US operations. The company plans a new multimillion dollar investment project to bring plastic transfer pipet and additional medical device manufacturing

AVI BioPharma will present data highlighting improved analogues of AVI’s phosphorodiamidate morpholino oligomer (PMO) chemistry. The data will be presented by Hong Moulton, director of Discovery Research. At

Nycomed and Forest Laboratories have announced results of four phase III trials published in The Lancet. Result showed that roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, improved lung function

Medgenics has announced that one of the patients treated with the EPODURE tissue Biopumps continues to be effectively treated for anemia without a single erythropoietin (EPO) injection. The

Arno Therapeutics (Arno) has reported the first patient dosing in a phase I clinical study of AR-12 (OSU-03012) in adult patients with advanced or recurrent solid tumors or

Sagent Pharmaceuticals has launched fluconazole injection in premix bags. Sagent will begin marketing and shipping fluconazole bags immediately. Ravi Malhotra, vice president of project management for Sagent Pharmaceuticals,

A study published by the scientists from UC Santa Barbara, claims of discovering a new drug delivery system. The new system is said to be a biological mechanism

Abbott has entered into an agreement with Pfizer to develop a molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors, for the presence of gene